Literature DB >> 30320759

Subtype-specific Optical Action Potential Recordings in Human Induced Pluripotent Stem Cell-derived Ventricular Cardiomyocytes.

Alexander Goedel1, Dorota M Zawada2, Fangfang Zhang2, Zhifen Chen3, Alessandra Moretti1, Daniel Sinnecker4.   

Abstract

Cardiomyocytes generated from human induced pluripotent stem cells (iPSC-CMs) are an emerging tool in cardiovascular research. Rather than being a homogenous population of cells, the iPSC-CMs generated by current differentiation protocols represent a mixture of cells with ventricular-, atrial-, and nodal-like phenotypes, which complicates phenotypic analyses. Here, a method to optically record action potentials specifically from ventricular-like iPSC-CMs is presented. This is achieved by lentiviral transduction with a construct in which a genetically-encoded voltage indicator is under the control of a ventricular-specific promoter element. When iPSC-CMs are transduced with this construct, the voltage sensor is expressed exclusively in ventricular-like cells, enabling subtype-specific optical membrane potential recordings using time-lapse fluorescence microscopy.

Entities:  

Mesh:

Year:  2018        PMID: 30320759      PMCID: PMC6235334          DOI: 10.3791/58134

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

Review 1.  Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.

Authors:  Mahmood Talkhabi; Nasser Aghdami; Hossein Baharvand
Journal:  Life Sci       Date:  2015-12-10       Impact factor: 5.037

2.  Developmental changes in electrophysiological characteristics of human-induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Meital Ben-Ari; Shulamit Naor; Naama Zeevi-Levin; Revital Schick; Ronen Ben Jehuda; Irina Reiter; Amit Raveh; Inna Grijnevitch; Omri Barak; Michael R Rosen; Amir Weissman; Ofer Binah
Journal:  Heart Rhythm       Date:  2016-09-14       Impact factor: 6.343

3.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

Review 4.  Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research.

Authors:  Alexander Goedel; Ilaria My; Daniel Sinnecker; Alessandra Moretti
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

5.  High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry.

Authors:  Subarna Bhattacharya; Paul W Burridge; Erin M Kropp; Sandra L Chuppa; Wai-Meng Kwok; Joseph C Wu; Kenneth R Boheler; Rebekah L Gundry
Journal:  J Vis Exp       Date:  2014-09-23       Impact factor: 1.355

6.  Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Christian B Jung; Alessandra Moretti; Michael Mederos y Schnitzler; Laura Iop; Ursula Storch; Milena Bellin; Tatjana Dorn; Sandra Ruppenthal; Sarah Pfeiffer; Alexander Goedel; Ralf J Dirschinger; Melchior Seyfarth; Jason T Lam; Daniel Sinnecker; Thomas Gudermann; Peter Lipp; Karl-Ludwig Laugwitz
Journal:  EMBO Mol Med       Date:  2012-01-25       Impact factor: 12.137

7.  Direct nkx2-5 transcriptional repression of isl1 controls cardiomyocyte subtype identity.

Authors:  Tatjana Dorn; Alexander Goedel; Jason T Lam; Jessica Haas; Qinghai Tian; Franziska Herrmann; Karin Bundschu; Gergana Dobreva; Matthias Schiemann; Ralf Dirschinger; Yanchun Guo; Susanne J Kühl; Daniel Sinnecker; Peter Lipp; Karl-Ludwig Laugwitz; Michael Kühl; Alessandra Moretti
Journal:  Stem Cells       Date:  2015-04       Impact factor: 6.277

8.  Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Marcella Rocchetti; Luca Sala; Lisa Dreizehnter; Lia Crotti; Daniel Sinnecker; Manuela Mura; Luna Simona Pane; Claudia Altomare; Eleonora Torre; Gaspare Mostacciuolo; Stefano Severi; Alberto Porta; Gaetano M De Ferrari; Alfred L George; Peter J Schwartz; Massimiliano Gnecchi; Alessandra Moretti; Antonio Zaza
Journal:  Cardiovasc Res       Date:  2017-04-01       Impact factor: 10.787

9.  Improving FRET dynamic range with bright green and red fluorescent proteins.

Authors:  Amy J Lam; François St-Pierre; Yiyang Gong; Jesse D Marshall; Paula J Cranfill; Michelle A Baird; Michael R McKeown; Jörg Wiedenmann; Michael W Davidson; Mark J Schnitzer; Roger Y Tsien; Michael Z Lin
Journal:  Nat Methods       Date:  2012-09-09       Impact factor: 28.547

10.  Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes.

Authors:  Zhifen Chen; Wenying Xian; Milena Bellin; Tatjana Dorn; Qinghai Tian; Alexander Goedel; Lisa Dreizehnter; Christine M Schneider; Dorien Ward-van Oostwaard; Judy King Man Ng; Rabea Hinkel; Luna Simona Pane; Christine L Mummery; Peter Lipp; Alessandra Moretti; Karl-Ludwig Laugwitz; Daniel Sinnecker
Journal:  Eur Heart J       Date:  2017-01-21       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.